blogtuan.info - Denmark recommends molnupiravir for high-risk patients
You are reading the article https://ift.tt/3IWPvZ6 at blogtuan.info latest news today
On December 16, Denmark became the first country in the European Union (EU) to recommend the use of the anti-viral drug Molnupiravir from US pharmaceutical company Merck’s to treat high-risk COVID-19 patients. . Molnupiravir was jointly developed by Merck and its American partner Ridgeback Biotherapeutics. Photo: AFP/VNA Molnupiravir, marketed as Lagevrio, was approved for emergency …
from latest news today blogtuan.info https://ift.tt/3IWPvZ6
via IFTTT
On December 16, Denmark became the first country in the European Union (EU) to recommend the use of the anti-viral drug Molnupiravir from US pharmaceutical company Merck’s to treat high-risk COVID-19 patients. . Molnupiravir was jointly developed by Merck and its American partner Ridgeback Biotherapeutics. Photo: AFP/VNA Molnupiravir, marketed as Lagevrio, was approved for emergency …
from latest news today blogtuan.info https://ift.tt/3IWPvZ6
via IFTTT
Nhận xét
Đăng nhận xét